Announcement
Mars, Incorporated announced the inauguration of a new Global Capability Center (GCC) in Hyderabad, India, in partnership with Genpact. The launch was marked on 12 November 2026 and underscores Mars’ deepening long‑term commitment to the Indian market.
Center Details
The Hyderabad GCC occupies approximately 60,000 square feet. At opening, it will be staffed by more than 400 Genpact colleagues, with a strategic plan to scale the workforce to 1,000 Mars Associates over time.
Strategic Purpose
The facility is designed to accelerate Mars’ digital, data and artificial intelligence capabilities. It will embed Genpact’s Agentic Operations platform to enhance operational speed, consistency and visibility across Mars’ global business, delivering AI‑assisted systems governed by a framework tailored to Mars.
Existing India Presence
Mars has been operating in India since 1995, having invested in seven local factories. The company currently employs over 2,400 Associates across its Snacking, Food & Nutrition, and Pet Nutrition segments, and runs a Royal Canin packaging centre.
Recent Investments
In addition to the GCC, Mars disclosed a $55 million expansion of its Hyderabad Pet Nutrition factory to support domestic growth and export demand, and a $12 million investment in a Royal Canin distribution and packaging centre aimed at strengthening localisation and supply‑chain resilience.
Executive Comments
Claus Aagaard, Chief Financial Officer of Mars, stated that India is a crucial market and that the new GCC will connect expertise across markets, enhancing agility and digital capability. D Sridhar Babu, IT and Industries Minister of Telangana, highlighted Hyderabad’s emergence as a leading GCC destination and welcomed the centre’s potential to create specialised talent opportunities. Tarun Chopra, Unit Leader – Consumer Goods at Genpact, explained that Genpact will apply its Agentic Operations to design AI‑enabled processes that deliver measurable business outcomes for Mars.
About Mars, Incorporated
Mars is a $65 billion+ family‑owned business (combined with Kellanova 2025 net sales) with a portfolio that includes brands such as ROYAL CANIN®, PEDIGREE®, WHISKAS®, M&M’S®, SNICKERS®, and PRINGLES®. The company employs roughly 170,000 Associates worldwide and operates pet hospitals and veterinary diagnostics services.
About Genpact
Genpact (NYSE: G) describes itself as an Agentic Operations company that combines frontier AI with context‑rich process intelligence, delivering mission‑critical operations for leading enterprises across finance, risk, supply chain, banking, insurance and procurement.